University of Washington

Health Systems and Population Health

SCHOOL OF PUBLIC HEALTH

The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective.


  1. Home


  2. The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective.


  3. The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective.

rakerr2

Campbell JD, Spackman DE, Sullivan SD. The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective. Allergy. 2010 Sep;65(9):1141-8. Epub 2010 Feb 10.

Upcoming Events

Full Calendar

News Categories